Skip to Content
MDPIMDPI

Advanced

Journal: CancersVolume: 14Number: 1751
Article: Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study
  • Authors:
  • Renaud Descourt 1,*,
  • Maurice Pérol 2 and
  • Christos Chouaïd 3
  • et al.
Link: https://www.mdpi.com/2072-6694/14/7/1751

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Order Type

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.